Zai Lab (ZLAB) News Today $28.04 -0.81 (-2.79%) As of 11:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZLAB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Zai Lab Secures RMB300 Million Debt FacilityOctober 16 at 11:45 PM | msn.comA Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data AnnouncementOctober 16 at 3:55 AM | finance.yahoo.comCould Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrative?October 16 at 3:55 AM | finance.yahoo.comZai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025October 15 at 8:03 AM | businesswire.comZai Lab falls -6.9%October 14 at 7:16 PM | msn.comZai Lab (NASDAQ:ZLAB) Trading Down 6.2% - Here's What HappenedOctober 14 at 2:07 PM | marketbeat.comZai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC ConferenceOctober 13, 2025 | businesswire.comZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Consensus Target Price from AnalystsOctober 13, 2025 | americanbankingnews.comZai Lab's (ZLAB) Sell (D-) Rating Reiterated at Weiss RatingsOctober 11, 2025 | americanbankingnews.comStocks Showing Improved Relative Strength: Zai Lab ADROctober 9, 2025 | msn.comWeiss Ratings Reaffirms Sell (D-) Rating for Zai Lab (NASDAQ:ZLAB)October 8, 2025 | marketbeat.comZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 8, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Still a Buy?September 30, 2025 | marketbeat.comZai Lab (ZLAB) Gets a Buy from Cantor FitzgeraldSeptember 21, 2025 | theglobeandmail.com29,693 Shares in Zai Lab Limited Unsponsored ADR $ZLAB Purchased by Acadian Asset Management LLCSeptember 18, 2025 | marketbeat.comZai Lab Limited (ZLAB): A Bull Case TheorySeptember 16, 2025 | finance.yahoo.comZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from BrokeragesSeptember 15, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Insider Buys $289,100.00 in StockSeptember 14, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's What HappenedSeptember 13, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Insider Acquires $289,100.00 in StockSeptember 13, 2025 | insidertrades.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Here's WhySeptember 12, 2025 | marketbeat.comZai Lab's Double Whammy: Earnings Miss, Phase 3 SetbackSeptember 11, 2025 | benzinga.comWoodline Partners LP Lowers Stock Holdings in Zai Lab Limited Unsponsored ADR $ZLABSeptember 11, 2025 | marketbeat.comZai Lab Limited (ZLAB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comZai Lab FY2026 EPS Forecast Lowered by Leerink PartnrsSeptember 9, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $3.38 Million Stock Position in Zai Lab Limited Unsponsored ADR $ZLABSeptember 8, 2025 | marketbeat.comRaymond James Financial Inc. Has $4.55 Million Holdings in Zai Lab Limited Unsponsored ADR $ZLABSeptember 8, 2025 | marketbeat.comInstitutional investors may overlook Zai Lab Limited's (NASDAQ:ZLAB) recent US$260m market cap drop as long-term gains remain positiveSeptember 6, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLABSeptember 6, 2025 | globenewswire.comZai Lab (NASDAQ:ZLAB) Stock Price Down 5.8% - Here's What HappenedSeptember 5, 2025 | marketbeat.comCanada Pension Plan Investment Board Buys Shares of 262,500 Zai Lab Limited Unsponsored ADR $ZLABSeptember 5, 2025 | marketbeat.comADAR1 Capital Management LLC Has $34 Million Stake in Zai Lab Limited Unsponsored ADR $ZLABSeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Raises Stock Position in Zai Lab Limited Unsponsored ADR $ZLABSeptember 4, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Buys New Shares in Zai Lab Limited Unsponsored ADR $ZLABSeptember 4, 2025 | marketbeat.comZai Lab to wait on results of FORTITUDE-102 prior to regulatory filingSeptember 3, 2025 | msn.comZai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer DrugSeptember 3, 2025 | msn.comZai Lab Limited Unsponsored ADR $ZLAB Shares Purchased by Invesco Ltd.September 2, 2025 | marketbeat.comZai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong KongSeptember 1, 2025 | businesswire.com107,997 Shares in Zai Lab Limited Unsponsored ADR $ZLAB Bought by OLD Mission Capital LLCSeptember 1, 2025 | marketbeat.com64,262 Shares in Zai Lab Limited Unsponsored ADR $ZLAB Acquired by Tema Etfs LLCAugust 30, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 193,978 Shares of Zai Lab Limited Unsponsored ADR $ZLABAugust 30, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Cuts Stock Holdings in Zai Lab Limited Unsponsored ADR $ZLABAugust 28, 2025 | marketbeat.comJefferies Financial Group Begins Coverage on Zai Lab (NASDAQ:ZLAB)August 27, 2025 | marketbeat.comCandriam S.C.A. Sells 134,538 Shares of Zai Lab Limited Unsponsored ADR $ZLABAugust 24, 2025 | marketbeat.comWellington Management Group LLP Has $131.81 Million Stock Holdings in Zai Lab Limited Unsponsored ADR $ZLABAugust 24, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Insider Sells $240,669.84 in StockAugust 21, 2025 | marketbeat.comZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from AnalystsAugust 21, 2025 | marketbeat.comZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) CFO Sells $50,933.96 in StockAugust 20, 2025 | marketbeat.comMY.Alpha Management HK Advisors Ltd Purchases New Shares in Zai Lab Limited Unsponsored ADR $ZLABAugust 20, 2025 | marketbeat.comZai Lab Points up as Chinese Gov’t Okays Tumor TreatmentAugust 19, 2025 | baystreet.ca Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼0.440.68▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼97▲ZLAB Articles Average Week Get the Latest News and Ratings for ZLAB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Zai Lab and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News Dr. Reddy's Laboratories News Viatris News Roivant Sciences News BridgeBio Pharma News Moderna News QIAGEN News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
